Adamax Dosage and Protocols
Adamax dosage protocols reported in published research, plus reconstitution and storage.
Dose Ranges and Protocol
No established clinical dosing protocol exists for Adamax. Extrapolating from Semax research, doses of 300–600 mcg once or twice daily via intranasal or subcutaneous administration are the most commonly reported research parameters. Intranasal delivery is the traditional route for Semax-class analogs due to proximity to the olfactory bulb and direct CNS access, though subcutaneous injection is also used in research settings. All dosing information is extrapolated from preclinical research on Semax analogs — no formal human dose-finding study has been conducted for Adamax.
Reconstitution
Adamax ships as a lyophilized powder. A common starting point is a 10 mg vial reconstituted with 2 mL bacteriostatic water, yielding 5,000 mcg/mL. A 500 mcg dose equals 0.1 mL (10 units on an insulin syringe). Add the water slowly down the vial wall, swirl gently (do not shake), and allow full dissolution. Reconstituted peptide should be refrigerated at 4°C and used within 7 days. Lyophilized powder is stable for ≥24 months when stored at −20°C protected from light and moisture.
Reported protocol doses
Reconstitution
A 10mg vial with 2mL of bacteriostatic water is the pairing reported most often. 10mg vial + 2mL bacteriostatic water = 5000mcg/mL. A 500mcg dose is 0.1mL (10 units on an insulin syringe).
Work out your own concentration with the reconstitution calculator.
Doses shown are those reported in published research, not a recommendation.